Viridium Becomes 100% Owner 0f Experion Biotechnologies Inc.
Calgary, Alberta (FSCwire) - Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR, OTCPink: MRRBF) announces that the previously announced share swap has been completed by which Viridium now owns all of the issued and outstanding shares of Experion Biotechnologies Inc. (“Experion”).
As announced on September 15, 2017, Experion and Northern Vine Canada Inc. (“Northern Vine”) entered into a swap agreement (the “Swap Agreement”) which resulted in Experion exchanging the 6,275 Northern Vine common shares it owned for the 2,500,000 Experion class “A” common shares owned by Northern Vine. The Swap Agreement has resulted in Northern Vine no longer owning any shares in Experion and Experion no longer owning any shares in Northern Vine. Experion is now a wholly owned subsidiary of Viridium.
About Viridium
Viridium owns Experion Biotechnologies Inc. Experion has been granted by Health Canada a ACMPR license to produce cannabis and it is proceeding to meet the Health Canada requirements to amend its current license to include a license to sell.
More information about Viridium can be found under the Company's profile on SEDAR at www.sedar.com.
Disclosure
The TSX Venture Exchange has in no way passed upon the merits of the proposed Reverse Take-over Transaction and has neither approved nor disapproved the contents of this news release.
This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.
Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.
For further information:
VIRIDIUM PACIFIC GROUP LTD.
John Zang
Corporate Secretary
Telephone: 403 680 9264
Email: jzanglaw@gmail.com
To view this press release as a PDF file, click onto the following link:public://news_release_pdf/Viridium10162017.pdf
Source: Viridium Pacific Group Ltd. (TSX Venture:VIR)
To follow Viridium Pacific Group Ltd. on your favorite social media platform or financial websites, please click on the icons below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 Filing Services Canada Inc.